Integration of oncology and palliative care: less-mentioned issues and a Japanese perspective

Affiliations

¹ Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan. Electronic address: tmorita@sis.seirei.or.jp.
² Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
³ Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan.

Comment

Yu Uneno et al. Lancet Oncol. 2018 Nov.

. 2018 Nov;19(11):e570-e571.

doi: 10.1016/S1470-2045(18)30486-8. Epub 2018 Oct 18.

¹ Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan. Electronic address: tmorita@sis.seirei.or.jp.
² Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
³ Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan.

No abstract available

Comment on

Integration of oncology and palliative care: a Lancet Oncology Commission.
Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, Brunelli C, Caraceni A, Cervantes A, Currow DC, Deliens L, Fallon M, Gómez-Batiste X, Grotmol KS, Hannon B, Haugen DF, Higginson IJ, Hjermstad MJ, Hui D, Jordan K, Kurita GP, Larkin PJ, Miccinesi G, Nauck F, Pribakovic R, Rodin G, Sjøgren P, Stone P, Zimmermann C, Lundeby T. Kaasa S, et al. Lancet Oncol. 2018 Nov;19(11):e588-e653. doi: 10.1016/S1470-2045(18)30415-7. Epub 2018 Oct 18. Lancet Oncol. 2018. PMID: 30344075 Review.